Suppr超能文献

俄勒冈州药剂师开具激素避孕处方的情况:基线知识及提供处方的意愿

Pharmacist prescription of hormonal contraception in Oregon: Baseline knowledge and interest in provision.

作者信息

Rodriguez Maria I, McConnell K John, Swartz Jonas, Edelman Alison B

出版信息

J Am Pharm Assoc (2003). 2016 Sep-Oct;56(5):521-6. doi: 10.1016/j.japh.2016.05.003.

Abstract

OBJECTIVES

Oregon has implemented legislation expanding the scope of pharmacists to directly prescribe short-acting hormonal contraception (pill and patch) without a medical prescription. Pharmacists are crucial to the success of the new law, but relatively little is known about their intentions to prescribe contraception, or the motivators or barriers in providing this service.

METHODS

With the use of a cross-sectional survey of pharmacists practicing in Oregon before the legislative implementation, we analyzed responses to assess contraceptive knowledge, motivation to participate in direct provision, and perception of barriers to pharmacist prescription of contraception. A logistic regression model was used to examine the association between years in pharmacy practice and intention to provide direct access to contraception.

RESULTS

A total of 509 pharmacists responded (17%). If training and reimbursement were offered, more than one-half of pharmacists would potentially be interested in prescribing contraception, managing side-effects, or moving women to a different hormonal method (57%, 61%, and 54%, respectively). However, only 39.1% of pharmacists surveyed planned to actually prescribe hormonal contraception when the legislation took effect. Shortage of pharmacy staff to provide services, concerns about liability, and a need for additional training were the three largest barriers to participation. Pharmacists practicing in urban locations (odds ratio 1.73, 95% CI 1.11-2.70) or currently offering emergency contraception (odds ratio 2.23, 95% CI 1.47-3.40) were significantly more likely to be planning to participate.

CONCLUSION

Preliminary data indicate a need to support pharmacists with education on contraceptive provision and development of interventions to facilitate counseling in the pharmacy setting.

摘要

目标

俄勒冈州已实施相关立法,扩大药剂师的职责范围,允许其在无医生处方的情况下直接开具短效激素避孕药(药片和贴片)。药剂师对于这项新法律的成功实施至关重要,但对于他们开具避孕药的意愿、提供此项服务的动机或障碍,我们了解得相对较少。

方法

在立法实施前,我们对俄勒冈州执业药剂师进行了横断面调查,分析他们的回复以评估避孕知识、参与直接提供服务的动机以及对药剂师开具避孕药的障碍认知。采用逻辑回归模型来检验药剂师从业年限与提供直接避孕服务意愿之间的关联。

结果

共有509名药剂师回复(回复率17%)。如果提供培训和报销,超过一半的药剂师可能有兴趣开具避孕药、处理副作用或为女性更换不同的激素避孕方法(分别为57%、61%和54%)。然而,在接受调查的药剂师中,只有39.1%计划在立法生效后实际开具激素避孕药。药房工作人员短缺以提供服务、对责任的担忧以及需要额外培训是参与这项服务的三大障碍。在城市地区执业的药剂师(优势比1.73,95%可信区间1.11 - 2.70)或目前提供紧急避孕服务的药剂师(优势比2.23,95%可信区间1.47 - 3.40)更有可能计划参与此项服务。

结论

初步数据表明,有必要为药剂师提供关于避孕服务的教育,并制定干预措施以促进药房环境中的咨询服务。

相似文献

1
Pharmacist prescription of hormonal contraception in Oregon: Baseline knowledge and interest in provision.
J Am Pharm Assoc (2003). 2016 Sep-Oct;56(5):521-6. doi: 10.1016/j.japh.2016.05.003.
2
Pharmacist Intentions to Prescribe Hormonal Contraception Following New Legislative Authority in California.
J Pharm Pract. 2019 Feb;32(1):54-61. doi: 10.1177/0897190017737897. Epub 2017 Nov 2.
3
Pharmacists' experience with prescribing hormonal contraception in Oregon.
J Am Pharm Assoc (2003). 2018 Nov-Dec;58(6):608-613. doi: 10.1016/j.japh.2018.06.020. Epub 2018 Sep 3.
4
Pharmacist interest in and attitudes toward direct pharmacy access to hormonal contraception in the United States.
J Am Pharm Assoc (2003). 2009 Jan-Feb;49(1):43-50. doi: 10.1331/JAPhA.2009.07154.
5
Availability of pharmacist prescription of contraception in rural areas of Oregon and New Mexico.
Contraception. 2020 Mar;101(3):210-212. doi: 10.1016/j.contraception.2019.11.005. Epub 2019 Dec 17.
6
Pharmacist Provision of Hormonal Contraception in the Oregon Medicaid Population.
Obstet Gynecol. 2019 Jun;133(6):1231-1237. doi: 10.1097/AOG.0000000000003286.
7
Prescription of Hormonal Contraception by Pharmacists in Oregon: Implementation of House Bill 2879.
Obstet Gynecol. 2016 Jul;128(1):168-170. doi: 10.1097/AOG.0000000000001474.
8
Pharmacist prescription and access to hormonal contraception for Medicaid-insured women in Oregon.
Contraception. 2020 Oct;102(4):262-266. doi: 10.1016/j.contraception.2020.07.001. Epub 2020 Jul 8.
9
Development of a pharmacist-provided contraceptive service following passage of Oregon House Bill 2879.
J Am Pharm Assoc (2003). 2019 Jul-Aug;59(4S):S112-S116. doi: 10.1016/j.japh.2019.02.014. Epub 2019 Apr 19.
10
Reasons for and experience in obtaining pharmacist prescribed contraception.
Contraception. 2020 Oct;102(4):259-261. doi: 10.1016/j.contraception.2020.05.016. Epub 2020 Jun 2.

引用本文的文献

1
Naloxone training programs in corporately-owned versus independently-owned Alabama community pharmacies: A pilot cross-sectional survey.
Drug Alcohol Depend Rep. 2025 Mar 28;15:100326. doi: 10.1016/j.dadr.2025.100326. eCollection 2025 Jun.
3
Minnesota Policy on Pharmacist-Prescribed Contraceptives: Benefits, Limitations, and Opportunities for Improvement.
Innov Pharm. 2021 Jun 10;12(3). doi: 10.24926/iip.v12i3.3923. eCollection 2021.
4
Community Pharmacists' Knowledge, Willingness, and Readiness to Prescribe Oral Contraceptives in Saudi Arabia.
Healthcare (Basel). 2022 Mar 9;10(3):503. doi: 10.3390/healthcare10030503.
5
North Carolina Pharmacists' Support for Hormonal Contraception Prescription Status Change.
J Pharm Pract. 2023 Aug;36(4):769-776. doi: 10.1177/08971900221074966. Epub 2022 Mar 24.
7
Enhancing access to contraception through pharmacist prescribing across Canada.
Can Pharm J (Ott). 2021 Sep 13;154(6):356-362. doi: 10.1177/17151635211034534. eCollection 2021 Nov-Dec.
8
Access to contraception in pharmacies during the COVID-19 pandemic.
J Am Pharm Assoc (2003). 2021 Nov-Dec;61(6):e65-e70. doi: 10.1016/j.japh.2021.08.002. Epub 2021 Aug 8.
10
Perspectives on pharmacy access to hormonal contraception among rural New Mexico women.
Contracept X. 2021 Jul 30;3:100069. doi: 10.1016/j.conx.2021.100069. eCollection 2021.

本文引用的文献

1
The acceptability of contraception task-sharing among pharmacists in Canada--the ACT-Pharm study.
Contraception. 2015 Jul;92(1):55-61. doi: 10.1016/j.contraception.2015.03.013. Epub 2015 Mar 27.
2
Committee opinion no. 615: Access to contraception.
Obstet Gynecol. 2015 Jan;125(1):250-255. doi: 10.1097/01.AOG.0000459866.14114.33.
3
Shifts in intended and unintended pregnancies in the United States, 2001-2008.
Am J Public Health. 2014 Feb;104 Suppl 1(Suppl 1):S43-8. doi: 10.2105/AJPH.2013.301416. Epub 2013 Dec 19.
4
Over-the-counter access to oral contraceptives as a reproductive healthcare strategy.
Curr Opin Obstet Gynecol. 2013 Dec;25(6):500-5. doi: 10.1097/GCO.0000000000000019.
5
Moving oral contraceptives over the counter as a strategy to reduce unintended pregnancy.
Ann Intern Med. 2013 Jun 4;158(11):839-40. doi: 10.7326/0003-4819-158-11-201306040-00629.
6
Committee Opinion No 544: Over-the-counter access to oral contraceptives.
Obstet Gynecol. 2012 Dec;120(6):1527-31. doi: 10.1097/01.AOG.0000423818.85283.bd.
7
The public costs of births resulting from unintended pregnancies: national and state-level estimates.
Perspect Sex Reprod Health. 2011 Jun;43(2):94-102. doi: 10.1363/4309411. Epub 2011 May 19.
8
Continuation of prescribed compared with over-the-counter oral contraceptives.
Obstet Gynecol. 2011 Mar;117(3):551-557. doi: 10.1097/AOG.0b013e31820afc46.
9
U S. Medical Eligibility Criteria for Contraceptive Use, 2010.
MMWR Recomm Rep. 2010 Jun 18;59(RR-4):1-86.
10
Pharmacist interest in and attitudes toward direct pharmacy access to hormonal contraception in the United States.
J Am Pharm Assoc (2003). 2009 Jan-Feb;49(1):43-50. doi: 10.1331/JAPhA.2009.07154.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验